Add this result to my export selection New Product: Hydrocortisone 10mg soluble tablets (Creo Pharma) Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 21 July 2020 This soluble tablet formulation of hydrocortisone is licensed for; congenital adrenal hyperplasia, asthma, hypersensitivity reactions, serum sickness, angioneurotic oedema, anaphylaxis, and treatment... Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPC: Maxitrol products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 29 June 2020 SPC now recommends that, because of the possibility of reduced glucose tolerance/diabetes mellitus with topical ophthalmic corticosteroids, caution is recommended when administering maxitrol to... Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Genotropin (somatropin) products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 Non-serious hyper sensitivity has been added as an adverse event to SPCs. Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Dolutegravir products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 The pregnancy information in SPCs has been updated in relation to the occurrence of neural tube defects with the dolutegravir regimens. Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Keppra (levetiracetam) products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 SPC now warns that as with other antiepileptics, levetiracetam may rarely exacerbate seizure frequency/severity. This paradoxical effect was mostly reported within 1st month after start of treatment... Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Zocor (simvastatin) film-coated tablets- all strenghts Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 The following adverse events have been added to SPCs: blurred vision and visual impairment (rare), lichenoid drug eruptions (very rare), muscle rupture (very rare), and gynecomastia (very rare). Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Cimzia (certolizumab pegol) 200 mg solution for injection in pre-filled pen and dose-dispenser cartridge Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 SPCs have been revised to advise that after at least 1 year of treatment, in patients with sustained remission, a reduced maintenance dose of 200 mg every 4 weeks may be considered in axial... Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Adcetris (brentuximab vedotin) 50 mg powder for concentrate for solution for infusion Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 SPCs have been revised to warn that elderly patients may be more susceptible to adverse events such as pneumonia, neutropenia and febrile neutropenia. Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: ABASAGLAR (insulin glargine) 100 units/mL solution for injection in a pre-filled pen and cartridge Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 Injection technique information has been expanded in SPCs to advise continuous rotation of injection site to reduce risk of lipodystrophy and cutaneous amyloidosis and warn of potential risk of... Read Summary Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Revised SPCs: Cosentyx (secukinumab) 150 mg solution for injection in pre-filled pen and syringe Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 05 August 2020 SPCs revised to warn that cases of new or exacerbations of inflammatory bowel disease (IBD) have been reported with secukinumab, therefore it not recommended in patients with IBD and should be... Read Summary Type: Prescribing and Technical Information (Add filter)